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Additional SourcesSign and Symptoms
TB remains a global health concern
due to its prevalence. While this disease
is curable, TB continues to rank as a
leading cause of death worldwide. As a
future nurse practitioner it is imperative
to understand the pathogenesis of TB,
mode of transmission, signs and
symptoms to aid in early diagnosis and
treatment. Ultimately, primary
preventive efforts must be enforced to
eradicate this deadly disease.
In summary, TB is a highly
contagious airborne disease that affects
millions around the world. Early
diagnosis and prompt treatment are
pivotal steps to stop the spread of TB and
help eradicate TB. As a future nurse
practitioner, understanding the
pathogenesis of TB can help tip the scale
to eliminate this deadly disease.
Tuberculosis (TB) is a disease that
claims the lives of millions each year. TB
is an airborne disease spread by inhaling
droplets of tubercle bacillus, once
penetrated in the alveoli, colonization of
droplets can multiply leading to
tuberculosis infection (Katanekwa &
Dahlback, 2016, p. 9). According to the
World Health Organization, TB is ranked
as one of the top leading causes of death
(WHO, 2018). While TB was discovered
over two thousand years ago by
Hippocrates, this disease continues to
claim lives each year (Katanekwa &
Dahlback, 2016, p.9)
Otterbein University, Westerville, Ohio
Figure 1. Incidence Rate of TB in 2016 (CDC, 2019)
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TB is spread through the air from person to person. “When a person with infectious
tuberculosis disease coughs, speaks, or sings, tiny particles containing M. tuberculosis
are expelled into the air, and are suspended into the air for up to several hours (Parmer,
Allen, & Walton, 2017, p. 26). Afterwards, if a person inhales those droplets, that
person may or may not be exposed to TB. According to Parmer, Allen, & Walton (2017),
latent TB infection occurs when an individual inhales droplet of nuclei containing the
microorganism tubercle bacilli (p. 27). After exposure, particulates of tubercle bacilli
that survive the alveoli multiply and spread through the blood stream. Afterwards, the
immune system of a healthy individual fights off the infection, thus inhibiting the
bacteria from multiplying and that same individual is categorized as having latent TB
infection. However, after exposure, if the immune system cannot stop the spread of
tubercle bacilli from multiplying, the individual is considered to have active TB disease.
Once an individual is suspected of having TB disease, further testing can confirm
diagnosis.
Underlying Pathophysiology
• “The Center for Disease Control and Prevention estimates that about 13 million
people living in the United States have latent TB infection, of which 85% lead to
active TB disease each year” (Parmer, Allen, & Walton, 2017,p. 27).
• “In 2017, 10 million people fell ill with TB, 1.6 million of those people died of the
disease” (WHO, 2019)
• TB Disease is extremely contagious, proper measures must be taken to prevent the
spread of infection
• The first line of treatment for TB disease is rifampicin. However, noncompliance
and misuse of this medication has led to drug resistance.
• “Multidrug-resistant TB (MDR-TB) remains a public health crisis and a health
security threat. WHO estimates that there were 558 000 new cases of TB with
resistance to rifampicin – the most effective first-line drug, of which - 82% had
MDR-TB” (WHO, 2019)
Significance of Pathophysiology
• Nearly four million cases of TB go 
undiagnosed each year (Fauci, 
2018, p. 1315).   
• According to Kurniatwati et al. 
(2016), five factors that play a role 
in TB compliance 
• knowledge about 
medication 
• self-discipline about 
medication and 
management
• ability in countering 
the adverse effects of 
medication 
• regularity in control 
and monitoring
• the ability in 
evaluating the result 
of treatment (p. 103)
• Non-compliance to 
TB treatment  is  a 
primary contributor 
to multi-drug 
resistance TB
• Education is an important step in 
prevention of active TB disease.
• Helping patients recognize risk 
factors associated with infectious 
TB, understanding the symptoms of 
TB , and getting screened can help 
stop the spread of active TB
• Furthermore, nurses must 
emphasize the importance of 
adhering to treatment plans.
• Knowledge gaps have led to 
development of multi-drug 
resistant strains that hinder 
treatment of TB.
There are 2 types of TB related
conditions, latent TB infection and
active TB disease.
Latent TB Infection
• Not contagious
• Asymptomatic- patient exhibits no
symptoms of active TB disease
• Negative Sputum culture
• Normal chest radiograph
• May have a positive skin test or
blood test
Latent TB can transition to active TB
disease if the immune system is
weakened. According to World Health
Organization, an individual with human
immunodeficiency virus (HIV) is at the
greatest risk for activating latent TB
(WHO, 2019).
Active TB Disease
• Highly contagious
• Persistent cough lasting > 3 weeks
• Loss of appetite
• Fatigue
• Weakness
• Weight loss
• Night sweats
• Fever
• Chest pain
• Coughing up blood or purulent 
sputum
• Abnormal chest radiograph
• Positive TB skin test or blood test
TB most commonly develops in the
lungs. However, TB can attack the brain,
kidneys, bone, and spine (Parmer, Allen,
& Walton, 2017, p. 26) .
Risk Factors
TB is more prevalent in under
developed countries. According to
Katanekwa and Dahlback (2016),
“overcrowded clinics, high patient load,
and staff shortage increases the risk of
developing occupational TB infection in
the developing countries” (p. 11). The
following are additional risk factors
that make an individual more
susceptible to developing TB disease
• Sharing living quarters with an 
individual who has active TB 
disease
• Over crowded living quarters
• Individuals with weakened 
immune systems(HIV, diabetes 
metilius, cancer) Nursing Implications
Latent TB
Daily dose of 
isoniazid
Treatment last 6-9 
months (CDC, 2016)
Active TB Disease
The most common 
treatment for active 
TB is isoniazid INH 
plus three other 
drugs—rifampin, 
pyrazinamide, and 
ethambutol.
Treatment last 6-12 
months(CDC, 2016)
Diagnostic Testing
• The most common form of diagnostic testing is skin test. Small amount of
fluid called tuberculin is injected intradermally on to the skin. After 48-72
hours, if the injected site is raised or has induration, the skin test is
considered positive for exposure to TB. Skin test is not indicative of active
TB (American Lung Association, 2019).
• Sputum Culture- lab technicians utilize microscopy to visualize for presence
of TB strains
• Microscopy cannot detect drug resistance strains (WHO,
2019)
• Blood test- Research has shown the XPERT-MTB/RIF assay is the best option
to obtain prompt results (WHO, 2019)
• Results are available within 2 hours
• Assay can detect presence of TB and drug resistance to
rifampicin (WHO, 2019)
“Between the year 2000 and 2017 an 
estimated 54 million lives were saved 
through TB diagnosis and treatment” 
(WHO, 2019)
Figure 2. Extrapulmonary Sites (Ford, 2017)
